Recalls / —
—#50565
Product
ARCHITECT Estradiol Reagent, each kit contains bottles of coated Microparticles and bottles of Conjugate; 400 Test Kit-list number 2K25-20 (4 x 100 tests) and 100 Test Kit-list number 2K25-25 (1 x 100 tests); Abbott Laboratories, Abbott Park, IL 60064-3500
- FDA product code
- CHP — Radioimmunoassay, Estradiol
- Device class
- Class 1
- Medical specialty
- Clinical Chemistry
- Affected lot / code info
- 400 Test Kit Lot Number: 42462M100 and 100 Test Kit Lot Number: 42462M101
Why it was recalled
A small number of reagent kits were incorrectly configured. The affected kits contain either two bottles of conjugate or two bottles of assay diluent instead of one bottle of each.
Root cause (FDA determination)
Other
Action the firm took
Abbott initiated a field correction recall by letter dated 2/19/07 to all customers receiving the affected reagent. The accounts were informed of the incorrectly configured reagent kits. The accounts were requested to assess the inventory for the affected lots of reagents, inspect each kit and destroy any kits incorrectly configured, recording the number of kits inspected and the number of kits discarded on the customer reply form and faxing it to Abbott by 3/2/07, indicating that the letter was received and understood. Replacement kits will be issued for the number of kits destroyed, as indicated on the reply sheet. Customers requiring additional information were directed to contact Abbott Customer Service at 1-877-422-2688.
Recalling firm
- Firm
- Abbott Laboratories
- Address
- 100 Abbott Park Rd, Abbott Park, Illinois 60064-3502
Distribution
- Distribution pattern
- Worldwide distribution including U.S.A., Puerto Rico, Canada, Mexico, Venezuela, Chile, Uruguay, Argentina, Brazil, Germany, Japan, Singapore, Hong Kong, Taiwan, Thailand, South Korea, Australia, New Zealand and Panama.
Timeline
- Recall initiated
- 2007-02-19
- Posted by FDA
- 2007-04-07
- Terminated
- 2008-01-09
- Status
- —
Source: openFDA Device Recall endpoint. Recall record ID #50565. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.